Review
doi: 10.1590/1806-9282.64.01.85.
Advances in early biomarkers of diabetic nephropathy
Affiliations
- PMID: 29561946
- DOI: 10.1590/1806-9282.64.01.85
Item in Clipboard
Review
Advances in early biomarkers of diabetic nephropathy
Rev Assoc Med Bras (1992).
2018 Jan.
Free article
Abstract
Diabetic nephropathy is the main cause of chronic kidney disease, and represents the most common and serious complication of diabetes. The exact pathogenesis is complex and not elucidated. Several factors and mechanisms contribute to the development and outcome of diabetic nephropathy. An early diagnosis and intervention may slow down disease progression. A variety of biological markers associated with diabetic nephropathy were found in recent years, which was important for predicting the occurrence and development of the disease. Therefore, this article provides an overview of early biomarkers that are associated with diabetic nephropathy.
Similar articles
-
Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis.Diabetes Metab Res Rev. 2017 Feb;33(2). doi: 10.1002/dmrr.2841. Epub 2016 Oct 4. Diabetes Metab Res Rev. 2017. PMID: 27457509 Review.
-
Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis.Rev Diabet Stud. 2015 Spring-Summer;12(1-2):110-8. doi: 10.1900/RDS.2015.12.110. Epub 2015 Aug 10. Rev Diabet Stud. 2015. PMID: 26676664 Free PMC article. Review.
-
Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature.Diab Vasc Dis Res. 2021 Nov-Dec;18(6):14791641211058856. doi: 10.1177/14791641211058856. Diab Vasc Dis Res. 2021. PMID: 34791910 Free PMC article. Review.
-
Early renal dysfunctions in type 1 diabetes and pathogenesis of diabetic nephropathy.J Nephrol. 2007 Nov-Dec;20 Suppl 12:S19-22. J Nephrol. 2007. PMID: 18050138 Review.
-
Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes.J Diabetes Complications. 2018 Feb;32(2):185-192. doi: 10.1016/j.jdiacomp.2017.10.014. Epub 2017 Nov 7. J Diabetes Complications. 2018. PMID: 29175120
Cited by
-
Depiction of immune heterogeneity of peripheral blood from patients with type II diabetic nephropathy based on mass cytometry.Front Endocrinol (Lausanne). 2023 Jan 6;13:1018608. doi: 10.3389/fendo.2022.1018608. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36686486 Free PMC article.
-
Effects of Shenkang Injection Combined with Jinshuibao on Early Diabetic Nephropathy and Effects on Coagulation Fibrinolysis System and Urinary Protein.Evid Based Complement Alternat Med. 2022 Oct 11;2022:3958049. doi: 10.1155/2022/3958049. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Dec 13;2023:9808315. doi: 10.1155/2023/9808315. PMID: 36267091 Free PMC article. Retracted.
-
Identification of a novel immune landscape signature as effective diagnostic markers related to immune cell infiltration in diabetic nephropathy.Front Immunol. 2023 Mar 8;14:1113212. doi: 10.3389/fimmu.2023.1113212. eCollection 2023. Front Immunol. 2023. PMID: 36969169 Free PMC article.
-
Protective Effect of Adalimumab on Diabetic Nephropathy by Regulating TNF-α Signal Pathway.Iran J Public Health. 2021 Dec;50(12):2536-2545. doi: 10.18502/ijph.v50i12.7936. Iran J Public Health. 2021. PMID: 36317034 Free PMC article.
-
The Key Role of Nutritional Intervention in Delaying Disease Progression and the Therapeutic Management of Diabetic Kidney Disease-A Challenge for Physicians and Patients.J Pers Med. 2024 Jul 23;14(8):778. doi: 10.3390/jpm14080778. J Pers Med. 2024. PMID: 39201970 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
